Products - Mesothelioma | Topic | NICE

Showing 1 product

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Pembrolizumab with pemetrexed and platinum-based chemotherapy for untreated unresectable advanced malignant pleural mesothelioma [ID4044]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
28 May 2025